Skip to main content
Clinical Trials/NCT01320384
NCT01320384
Completed
Phase 2

Clinical Effect of the Association of Noninvasive Ventilation and High Flow Nasal Oxygen Therapy in Resuscitation of Patients With Acute Lung Injury. A Randomised Study (FLORALI Study)

Poitiers University Hospital1 site in 1 country313 target enrollmentMarch 2011

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Acute Lung Injury
Sponsor
Poitiers University Hospital
Enrollment
313
Locations
1
Primary Endpoint
To compare the number of patients in each group who require endotracheal intubation with mechanical ventilation
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

The aim of the study is to compare, in patients with acute respiratory failure/acute lung injury the efficacy of three different methods of oxygenation to prevent endotracheal intubation :

  1. conventional oxygen therapy (O2 conventional)
  2. high flow nasal oxygen therapy (O2-HFN)
  3. association of high flow nasal oxygen therapy with non invasive positive pressure ventilation (O2-HFN/NPPV).
Registry
clinicaltrials.gov
Start Date
March 2011
End Date
July 2013
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Hypoxemic and no hypercapnic acute respiratory failure :
  • severe dyspnea at rest with a respiratory rate \>25 breaths/min
  • PaO2/FiO2 \<300
  • PaCO2 \<45 mmHg,

Exclusion Criteria

  • age \<18 years
  • NPPV contraindications
  • past history of respiratory chronic disease (COPD, cystic fibrosis...)
  • cardiac pulmonary edema
  • Pre-defined intubation
  • other than respiratory organ failure : systolic pressure \<90 mmHg,current treatment with epinephrine or norepinephrine, decreased level of consciousness ( Glasgow score ≤ 12)
  • profound aplasia (white cells count \<1000/mm 3)

Outcomes

Primary Outcomes

To compare the number of patients in each group who require endotracheal intubation with mechanical ventilation

Time Frame: at day 28

Secondary Outcomes

  • mechanical ventilation-free to day 28(28 days)
  • ICU morbidity(at day 28)

Study Sites (1)

Loading locations...

Similar Trials